EMJ Capital_Block_White

Amazon Pharma Move Results in $5B Dive for GoodRx

On November 20, 2020, a Bloomberg article describes how Good Rx got caught in the crosshairs of an Amazon Pharma move, resulting in a $5 billion dive. 

Good Rx CEO, Douglas Hirsch, is not concerned due to high barriers to entry for new players in the space. He also stated that Amazon is a partner, not a competitor.

EMJ Founder, Eric Jackson, is noted in the Bloomberg article for taking advantage of a good buying opportunity for his hedge fund.

Read the Bloomberg article featured on Yahoo! Finance: “GoodRx CEO Shrugs Off $5 Billion Dive on Amazon Pharma Move”.

GoodRx Stock Chart

Subscribe to the EMJ Capital Tech & Media eNews

Sign up to receive Eric’s latest writings on the tech industry. You will receive them in your inbox before they are published anywhere else.